Remove Molecular Biology Remove Vaccine Remove Workshop
article thumbnail

Turning science into business: Merging AI and RNA

Drug Discovery World

For RNA, we’ve seen its success with Covid-19 vaccines and the approval of the first-ever RNA-targeting small molecule, risdiplam, for treating spinal muscular atrophy (SMA). The recent wins with the Covid-19 vaccines and the risdiplam approval demonstrate the potential of RNA. RT : We are just getting started in the RNA space.

RNA 130
article thumbnail

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

As such, the synthesis of DNA oligonucleotides for routine molecular biology applications is often outsourced to service provider companies that operate DNA synthesisers to meet these demands. . If you want to order gene-length sequences, rather than short oligos for PCR, the waiting times are around two or three weeks at least.

DNA 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Analysis Life Sciences Thank You Revised ICH viral safety guideline: NGS is in, animal use (mostly) out

Agency IQ

Though some biological products may be developed using PCCs, such as viral vaccines, these cultures are also commonly used for in vitro experiments that seek to mimic in vivo conditions as closely as possible (e.g., for renal function studies ). Secondly, their use minimizes both the risk and the impact of viral contamination.

Virus 40
article thumbnail

A Protein Printer

Codon

We are living through an inflection point in biology’s history, in which a simple laptop can design proteins with wondrous new functions. Scientists at the Institute for Protein Design have crafted proteins that self-assemble into nanomaterials or that can be used as vaccines for the flu and HIV.

RNA 64
article thumbnail

A Protein Printer

Codon

We are living through an inflection point in biology’s history, in which a simple laptop can design proteins with wondrous new functions. Scientists at the Institute for Protein Design have crafted proteins that self-assemble into nanomaterials or that can be used as vaccines for the flu and HIV.

RNA 52